The Animal Auto-Immune Disease Diagnostics Market is witnessing significant growth, estimated at USD 6.2 billion in 2025 and projected to reach USD 11.3 billion by 2035, growing at a CAGR of 6.2%.

Fintel reports that on October 8, 2025, Evercore ISI Group maintained coverage of Quest Diagnostics (NYSE:DGX) with a In-Line recommendation. Analyst Price Forecast Suggests 5.78% Upside As of ...

In the latest quarter, 7 analysts provided ratings for Quest Diagnostics (NYSE:DGX), showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, showcasing ...

One thing I really noticed about Everlywell is how woman-centered it felt. Many health platforms can feel transactional—here’s your data, good luck figuring it out. But Everlywell emphasized context ...

On Tuesday, the College of Healthcare Information Management Executives (CHIME) held an event to launcha $1 millionglobal competition -- the National Patient ID Challenge--that incentivizes innovators ...

Quest Diagnostics can benefit from continued demand for specific diagnostic testing across a broad range of clinical areas. Read why DGX stock is a Buy.

WHOOP, the human performance company, today announced the launch of WHOOP Advanced Labs, a groundbreaking new feature that combines blood testing with ...

Fintel reports that on October 2, 2025, Barclays maintained coverage of Quest Diagnostics (NYSE:DGX) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 5.77% Upside As of September 30 ...